Neo Ivy Capital Management’s ResMed RMD Stock Holding History

Neo Ivy Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,476	Closed	-$2.96M	–	378
2024 Q2	$2.96M	Buy	+15,476	New	+$3.14M	0.58%	78
2023 Q3	–	Sell	-5,463	Closed	-$1.19M	–	437
2023 Q2	$1.19M	Buy	+5,463	New	+$1.22M	0.63%	49
2022 Q4	$885K	Buy	+4,254	New	+$935K	0.6%	37
2020 Q4	–	Sell	-2,064	Closed	-$353K	–	549
2020 Q3	$353K	Buy	+2,064	New	+$381K	0.36%	97
2020 Q2	–	Sell	-352	Closed	-$52K	–	579
2020 Q1	$52K	Buy	+352	New	+$56.1K	0.08%	302

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Neo Ivy Capital Management's RMD Position: Q3 2024 in Review

Neo Ivy Capital Management sold out of ResMed (RMD) in Q3 2024, closing a stake of 15,476 shares — an estimated $2.96M sold.

Neo Ivy Capital Management first reported a position in RMD in Q1 2020 and held it in 5 quarters. The position peaked at $2.96M in Q2 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

Neo Ivy Capital Management reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
Neo Ivy Capital Management sold 15,476 ResMed shares in Q3 2024, an estimated $2.96M.
Neo Ivy Capital Management first reported a position in ResMed in Q1 2020 and held it in 5 quarters.
Neo Ivy Capital Management's ResMed position peaked at $2.96M in Q2 2024.
801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Neo Ivy Capital Management's 13F filing for Q3 2024, filed 18 Nov 2024.